Bristol-Myers Squibb Company (BMY) · page 187 of 197
Uses a combination of qualitative testimonials and quantitative benchmarking (Amgen's 3% improvement) to argue for operational change.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
callout 1/1 paragraph 1/1 quote 3/3 source-note 1/1 title 2/2
Components 8
primary paragraph testimonial testimonial testimonial source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1